BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 35509083)

  • 1. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.
    Zhu L; Yang X; Feng J; Mao J; Zhang Q; He M; Mi Y; Mei Y; Jin G; Zhang H
    J Transl Med; 2022 May; 20(1):194. PubMed ID: 35509083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASPM promotes hepatocellular carcinoma progression by activating Wnt/β-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation.
    Zhang H; Yang X; Zhu L; Li Z; Zuo P; Wang P; Feng J; Mi Y; Zhang C; Xu Y; Jin G; Zhang J; Ye H
    FEBS Open Bio; 2021 Oct; 11(10):2784-2799. PubMed ID: 34428354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
    Zhao J; Wang Y; Han M; Lu H; Chen X; Liu S; Yuan X; Han K; Liang P; Cheng J
    Cancer Sci; 2020 Mar; 111(3):994-1007. PubMed ID: 31746531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
    Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
    World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway.
    Liu Y; Ma J; Lu S; He P; Dong W
    Chin Med J (Engl); 2023 Sep; 136(18):2229-2242. PubMed ID: 37439386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
    J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
    Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
    J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.
    Zhang C; Li C; Chen X; Zhou Y; Yin B; Ni R; Zhang Y; Liu J
    Clin Transl Oncol; 2017 Dec; 19(12):1507-1517. PubMed ID: 28589433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma.
    Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL
    BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
    Hu Z; Wang P; Lin J; Zheng X; Yang F; Zhang G; Chen D; Xie J; Gao Z; Peng L; Xie C
    Cell Physiol Biochem; 2018; 51(1):470-486. PubMed ID: 30453289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
    Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
    Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W
    Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627
    [No Abstract]   [Full Text] [Related]  

  • 15. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z; Zhang Y; Xu Z
    J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
    Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
    Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogel-based miR-192 delivery inhibits the development of hepatocellular carcinoma by suppressing the GSK3β/Wnt/β-catenin pathway.
    Yang Q; Zhuge X; Lin W; Yu W; Zhu Y; Shi C; Shi Z
    Neoplasma; 2023 Aug; 70(4):555-565. PubMed ID: 37789778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway.
    Tang H; Zhao H; Yu ZY; Feng X; Fu BS; Qiu CH; Zhang JW
    Dig Liver Dis; 2019 Sep; 51(9):1314-1322. PubMed ID: 30948333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.